$945 Million is the total value of ARCH Venture Management, LLC's 9 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KRTX | New | KARUNA THERAPEUTICS, INC. | $381,586,000 | – | 2,912,872 | +100.0% | 40.37% | – |
| New | EQRX, INC. | $247,807,000 | – | 36,335,375 | +100.0% | 26.22% | – | |
| New | ERASCA, INC. | $172,246,000 | – | 11,055,554 | +100.0% | 18.22% | – | |
| VERV | New | VERVE THERAPEUTICS, INC. | $92,500,000 | – | 2,508,809 | +100.0% | 9.79% | – |
| OMIC | New | SINGULAR GENOMICS SYSTEMS, INC. | $43,916,000 | – | 3,798,926 | +100.0% | 4.65% | – |
| RUBY | New | RUBIUS THERAPEUTICS, INC. | $3,387,000 | – | 349,908 | +100.0% | 0.36% | – |
| NTRA | New | NATERA, INC. | $2,998,000 | – | 32,098 | +100.0% | 0.32% | – |
| ZY | New | ZYMERGEN INC. | $797,000 | – | 119,205 | +100.0% | 0.08% | – |
| PULM | New | PULMATRIX, INC. | $19,000 | – | 43,639 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| RUBIUS THERAPEUTICS, INC. | 12 | Q3 2022 | 65.5% |
| EQRX, INC. | 8 | Q3 2023 | 52.4% |
| ERASCA, INC. | 8 | Q3 2023 | 18.8% |
| VERVE THERAPEUTICS, INC. | 8 | Q3 2023 | 23.3% |
| CHIASMA INC | 8 | Q3 2020 | 25.7% |
| SINGULAR GENOMICS SYSTEMS, INC. | 8 | Q3 2023 | 4.6% |
| KURA ONCOLOGY INC | 7 | Q2 2020 | 27.6% |
| KARUNA THERAPEUTICS, INC. | 6 | Q1 2023 | 52.8% |
| DENALI THERAPEUTICS, INC. | 6 | Q3 2023 | 28.6% |
| SYROS PHARMACEUTICALS INC | 5 | Q3 2020 | 43.8% |
View ARCH Venture Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-09 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-15 |
| 13F-HR/A | 2022-05-27 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
View ARCH Venture Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.